Aerpio Therapeutics
Pipeline
(click on a compound for more information)
About
Aerpio Therapeutics is a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases.
Learn more...News
9/19/12 - Aerpio Therapeutics Initiates Phase 1b/2a Trial of AKB-9778 in Diabetic Macular Edema
Read the press release.8/30/12 - Aerpio Therapeutics Completes $27 Million Series A Financing
Read the press release.8/22/12 - Aerpio Therapeutics Hosts Scientific Symposium on Tie2 Pathway
Read the press release.